Donor-specific HLA alloantibodies: Long-term impact on cardiac allograft vasculopathy and mortality after heart transplant

Experimental and Clinical Transplantation

Volumn 6, Issue 3, 2008, Pages 229-235

  Kaczmarek, Ingo ^a   Deutsch, Marcus André ^a   Kauke, Teresa ^a   Beiras Fernandez, Andres ^a   Schmoeckel, Michael ^a   Vicol, Calin ^a   Sodian, Ralf ^a   Reichart, Bruno ^a   Spannagl, Michael ^a   Ueberfuhr, Peter ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Antibody mediated rejection; Cardiac allograft vasculopathy; Donor specific antibodies; Histocompatibility; Humoral rejection

Indexed keywords

ALLOANTIBODY; HLA ANTIGEN;

ADULT; ANTIBODY PRODUCTION; ARTICLE; BLOOD; CONGESTIVE CARDIOMYOPATHY; DONOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDY; SURVIVAL; SURVIVOR; TIME;

ADULT; ANTIBODY FORMATION; CARDIOMYOPATHY, DILATED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HEART TRANSPLANTATION; HLA ANTIGENS; HUMANS; ISOANTIBODIES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SURVIVORS; TIME FACTORS; TISSUE DONORS;

EID: 58149280266     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Taylor DO, Edwards LB, Boucek MM, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report-2007. J Heart Lung Transplant. 2007;26(8):769-781.
2. Colvin RB, Smith RN. Antibody-mediated organ-allograft rejection. Nat Rev Immunol. 2005;5(10):807-817.
3. Terasaki PI. Humoral theory of transplantation. Am J Transplant. 2003;3(6):665-673.
4. Reed EF, Demetris AJ, Hammond E, et al. Acute antibody-mediated rejection of cardiac transplants. J Heart Lung Transplant. 2006;25(2):153-159.
5. Mitchell RN, Libby P. Vascular remodeling in transplant vasculopathy. Circ Res. 2007;100(7):967-978.
6. Rahmani M, Cruz RP, Granville DJ, McManus BM. Allograft vasculopathy versus atherosclerosis. Circ Res. 2006;99(8):801-815.
7. Uber WE, Self SE, Van Bakel AB, Pereira NL. Acute antibody-mediated rejection following heart transplantation. Am J Transplant. 2007;7(9):2064-2074.
8. Reinsmoen NL, Nelson K, Zeevi A. Anti-HLA antibody analysis and crossmatching in heart and lung transplantation. Transpl Immunol. 2004;13(1):63-71.
9. Wehner J, Morrell CN, Reynolds T, Rodriguez ER, Baldwin WM 3rd. Antibody and complement in transplant vasculopathy. Circ Res. 2007;100(2):191-203.
10. Takemoto SK, Zeevi A, Feng S, et al. National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant. 2004;4(7):1033-1041.
11. Fishbein MC, Kobashigawa J. Biopsy-negative cardiac transplant rejection: etiology, diagnosis, and therapy. Curr Opin Cardiol. 2004;19(2):166-169.
12. Michaels PJ, Espejo ML, Kobashigawa J, et al. Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. J Heart Lung Transplant. 2003;22(1):58-69.
13. Stastny P, Lavingia B, Fixler DE, Yancy CW, Ring WS. Antibodies against donor human leukocyte antigens and the outcome of cardiac allografts in adults and children. Transplantation. 2007;84(6):738-745.
14. Kaczmarek I, Ertl B, Schmauss D, et al. Preventing cardiac allograft vasculopathy: long-term beneficial effects of mycophenolate mofetil. J Heart Lung Transplant. 2006;25(5):550-556.
15. Keogh A, Richardson M, Ruygrok P, et al. Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial. Circulation. 2004;110(17):2694-2700.
16. Kaczmarek I, Deutsch MA, Rohrer ME, et al. HLA-DR matching improves survival after heart transplantation: is it time to change allocation policies? J Heart Lung Transplant. 2006;25(9):1057-1062.
17. Tambur AR, Pamboukian SV, Costanzo MR, et al. The presence of HLA-directed antibodies after heart transplantation is associated with poor allograft outcome. Transplantation. 2005;80(8):1019-1025.
18. Vasilescu ER, Ho EK, de la Torre L, et al. Anti-HLA antibodies in heart transplantation. Transpl Immunol. 2004;12(2):177-183.
19. Deng MC, Eisen HJ, Mehra MR, et al. Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant. 2006;6(1):150-160.
20. Horwitz PA, Tsai EJ, Putt ME, et al. Detection of cardiac allograft rejection and response to immunosuppressive therapy with peripheral blood gene expression. Circulation. 2004;110(25):3815-3821.
21. Girnita AL, Webber SA, Zeevi A. Anti-HLA alloantibodies in pediatric solid organ transplantation. Pediatr Transplant. 2006;10(2):146-153.
22. Bray RA, Nickerson PW, Kerman RH, Gebel HM. Evolution of HLA antibody detection: technology emulating biology. Immunol Res. 2004;29(1-3):41-54.
23. Vaidya S, Partlow D, Susskind B, Noor M, Barnes T, Gugliuzza K. Prediction of crossmatch outcome of highly sensitized patients by single and/or multiple antigen bead luminex assay. Transplantation. 2006;82(11):1524-1528.
24. Duquesnoy RJ, Takemoto S, de Lange P, et al. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. III. Effect of matching at the HLA-A,B amino acid triplet level on kidney transplant survival. Transplantation. 2003;75(6):884-889.
25. Zangwill SD, Ellis TM, Zlotocha J, et al. The virtual crossmatch-a screening tool for sensitized pediatric heart transplant recipients. Pediatr Transplant. 2006;10(1):38-41.
26. Kaczmarek I, Deutsch MA, Sadoni S, et al. Successful management of antibody-mediated cardiac allograft rejection with combined immunoadsorption and anti-CD20 monoclonal antibody treatment: case report and literature review. J Heart Lung Transplant. 2007;26(5):511-515.
27. Suárez-Alvarez B, López-Vázquez A, Gonzalez MZ, et al. The relationship of anti-MICA antibodies and MICA expression with heart allograft rejection. Am J Transplant. 2007;7(7):1842-1848.
28. Mahesh B, Leong HS, McCormack A, Sarathchandra P, Holder A, Rose ML. Autoantibodies to vimentin cause accelerated rejection of cardiac allografts. Am J Pathol. 2007;170(4):1415-1427.